AzTrials
AzTrials

Cervical CancerHPVNCT03386695

Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra

A study testing Education by Pamphlets and Health education programme in people with Cervical Cancer, run by Tata Memorial Hospital at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study goals are, 1. To determine the test characteristics (sensitivity, specificity, positive predictive value, negative predictive value, false positivity rates, false negativity rates) of health personnel collected and self collected HPV samples for Hybrid capture explained by two different methods (pamphlets/… Read more about this study

Who is it for?
Ages 30 to 55 years, women onlyHealthy volunteers can take part
Conditions the study is for
Cervical Cancer
What is being tested?
Education by Pamphlets and Health education programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,600 participants
Where
1 siteIndia
Study dates
Sep 2018to Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 55 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Sexually active women in the age group of 30-55 years in the selected areas.

Who cannot join

  • Pregnant women
  • Women having frank cervical cancer
  • Women who have undergone total hysterectomy

Trial locations and contacts

1 site in 1 country.

Gauravi A Mishra, M.D PSM contact

+912224177000 ext. 4634

gauravi2005@yahoo.co.in

Sharmila A Pimple, M.D PSM contact

+912224154379

drsharmilapatil@yahoo.co.com

India1 site
  • Tata Memorial Hospital

    Mumbai, Maharashtra, 400012

    Dr. Gauravi A Mishra, M.D PSM, +912224177000 ext. 4634, gauravi2005@yahoo.co.in

    Dr. gauravi A Mishra, M.D PSM

Other trials in India

About this study

The study goals are,

  1. To determine the test characteristics (sensitivity, specificity, positive predictive value, negative predictive value, false positivity rates, false negativity rates) of health personnel collected and self collected HPV samples for Hybrid capture explained by two different methods (pamphlets/ health education programme).
  2. To evaluate the agreement between self collected HPV samples and health personnel collected HPV samples for Hybrid capture with two different methods of education (pamphlets/ health education programme).
  3. To study the attitudes, acceptability and barriers of self-collection of specimens for HPV DNA testing in three sub groups of population in Maharashtra with two different methods of education (pamphlets/ health education programme).
  4. To determine the predictors of self-sampling preference.
  5. To determine the Knowledge, Attitudes and Practices (KAP) regarding cervical cancer and HPV infection among these women in pre-intervention and post-intervention period.
Read the detailed description

The three communities, urban slum area in Mumbai, urban non slum area in Mumbai and rural area in Raigad/ Thane district will be selected. The eligible women will be contacted by door to door visit and the purpose of the campaign will be explained to them. Informed consent will be obtained from those who are willing to participate in the study.

Step 1: They will be interviewed to collect the baseline Knowledge, Attitude and Practices (KAP) regarding cervical cancer, screening and HPV. The information will be recorded on a structured questionnaire.

Step 2: Half of the women in each group will be invited to specially organized camps in their neighborhood for Health Education and distribution of self samplers while the other half will be provided an information pamphlet on the risk factors, methods of early detection, prevention, signs and symptoms of cervical cancer and how to use the self samplers at home. Similar personal interviews, collection of used/unused self sampler and collection of HPV samples by health worker will be followed for both groups of women.

Intervention one: (Health Education Group) Detailed health education programme explaining them the risk factors, methods of early detection, prevention, signs and symptoms of cervical cancer will be conducted. They will be explained the importance of getting screened for cervical cancer and will be encouraged to undergo screening at any nearby screening centre. They will be given information regarding HPV self samplers and will be taught the method of its use and storage in detail. Any queries with this regard will be answered.

Intervention two: (Both Groups) HPV self samplers will be distributed free of cost to the women and the social workers will instruct them to return it to the clinic or will collect the samplers from their houses, either on the same day or the following day as per the convenience of the woman. For HPV self collection the participating women will be asked to collect the sample specimen as per instructions provided during the health education session/ pamphlets and store it at room temperature till the time of collection by the social worker. The willingness to use self sampler or refusal to use the HPV self sampler will be captured. Also, the reasons for their refusal shall be captured.

Step 3: (Both Groups) During the visit by social worker to collect the samples, the women will be again interviewed by the social worker for their experience about collecting the sample at home. Personal interviews will be conducted also to assess their acceptability of self sampling for HPV detection. Various queries regarding difficulties in obtaining, storing and transporting the samples as well as other potential factors likely to affect the acceptability of the self sampling methods will be assessed. Any injuries, barriers and motivators for self sampling will be recorded. The women who refuse to use self samplers at this stage will also be interviewed to understand the barriers. HPV sample will be collected by the health worker when the woman comes to return the sampler kit. It will also be collected for women who refuse self sampling but are ready for health worker collected sample.

Information about the post-intervention KAP regarding cervical cancer, screening and HPV will be again recorded on a structured questionnaire from all women.

Step 4: (Both Groups) HPV testing will be performed with the Hybrid Capture System II {Digene}, which detects 13 different high-risk HPV types {16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68}. The test will run according to the manufacturer's protocol. HPV determination will be quantitative, and women with samples producing readings of one or more times the positive control (1pg/ml HPV DNA) will be considered as HPV test positive.

Step 5: (Both Groups) The reports of self sampling HPV will be distributed to the women after 15 days. The women who test positive on either test will be contacted personally by staff or by telephone and will be offered free Preventive Oncology check up, Colposcopy and necessary work up either at Tata Memorial Hospital. The women not willing to avail facility at TMH will be referred to the nearby municipal or private hospital offering these services.

The women who are positive or negative on colposcopy will undergo further diagnosis and management as per departmental service protocol. The health worker will co-ordinate between the field staff and the various departments at TMH. The health worker will submit the samples to the department of Microbiology at the TMH, will collect the reports and send it to the field social workers for distribution, will assist the HPV positive patients for further investigations and diagnosis at the TMH.

Conditions
Cervical Cancer
Being tested
Education by Pamphlets, Health education programme
Keywords
Cervical Cancer and HPV infection
Medical subject headings
Uterine Cervical Neoplasms, Papillomavirus Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Education by PamphletsOther

    Distribution of pamphlets with information of prevention and early detection of cervical cancer and written as well as pictorial depiction on how to collect cervical self sample for HPV detection.

  • Health education programmeOther

    Health education program explaining about prevention and early detection of cancer and education on method of collection of cervical self sample for HPV.

Study groups in NCT03386695
Study groupRoleWhat they receive
Education by PamphletsOtherHalf of the women in each group will be provided an information pamphlet on the risk factors, methods of early detection, prevention, signs and symptoms of cervical cancer and how to use the self samplers at home.
Receives: Other: Education by Pamphlets
Health education programmeOtherHalf of the women in each group will be invited to specially organised camps in their neighbourhood for Health Education and distribution of self samplers.
Receives: Other: Health education programme

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Agreement rate between health care personnel collected samples and self collected samples in these two groups.

    Results obtained out of the health care personnel collected samples Vs self collected samples and correspondingly results of the test among women taught to use self samplers with the aid of pamphlets as compared to a well conducted health education programme will be evaluated using kappa statistics.

    Measured: 18 months

Secondary outcomes (2)
  1. Test characteristics of HPV self sample and health care worker collected sample by HPV HC 2.

    sensitivity, specificity, positive predictive value, negative predictive value, false positive rate and false negative rate will be calculated for self collected HPV samples and health personnel collected HPV samples

    Measured: 18 months

  2. Acceptability and barriers for self-collection of specimens for HPV DNA testing in an urban population.

    The acceptability and barriers for self collection of specimens for HPV DNA test will be calculated by using multiple logistic regression analysis for various socio-demographic and risk factors and my recording of reasons for the same

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2017
  2. Study startSep 2018 (estimated)
  3. Primary completionJan 2019 (estimated)
  4. Study completionJan 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
1,600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03386695
Sponsor's protocol ID
TMHPO 1686
Acronym
HPV
Status last verified
Aug 2018
First submitted
18 Apr 2017
Last updated
6 Aug 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Education by Pamphlets and Health education programme in people with Cervical Cancer, run by Tata Memorial Hospital at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gauravi A Mishra, M.D PSM (+912224177000 ext. 4634, gauravi2005@yahoo.co.in), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Agreement rate between health care personnel collected samples and self collected samples in these two groups. (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
HPV Clinical Trial NCT03386695 | AzTrials